Related Experiment Video
Updated: Aug 8, 2025

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Suspected COVID-19 mRNA Vaccine-Induced Postural Orthostatic Tachycardia Syndrome
Nicole Maharaj1, Steven Swarath1, Rajeev Seecheran2
1Medicine, North Central Regional Health Authority, Port of Spain, TTO.
Abstract:
We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.
Related Concept Videos
Dysrhythmias II: Classification of Tachyarrhythmias
Equilibrium and Balance
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Mechanism of Cardiac Arrhythmias

